INAB
Price
$1.68
Change
-$0.05 (-2.89%)
Updated
Dec 12 closing price
Capitalization
7.79M
Intraday BUY SELL Signals
SNSE
Price
$8.55
Change
-$0.45 (-5.00%)
Updated
Dec 12 closing price
Capitalization
10.78M
Intraday BUY SELL Signals
Interact to see
Advertisement

INAB vs SNSE

Header iconINAB vs SNSE Comparison
Open Charts INAB vs SNSEBanner chart's image
IN8bio
Price$1.68
Change-$0.05 (-2.89%)
Volume$86.12K
Capitalization7.79M
Sensei Biotherapeutics
Price$8.55
Change-$0.45 (-5.00%)
Volume$22.59K
Capitalization10.78M
INAB vs SNSE Comparison Chart in %
INAB
Daily Signal:
Gain/Loss:
SNSE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.21B. The market cap for tickers in the group ranges from 58 to 114.69B. VRTX holds the highest valuation in this group at 114.69B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 65%. NBY experienced the highest price growth at 158%, while BPTSY experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was 72%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 80
Price Growth Rating: 54
SMR Rating: 92
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)

Market Cap

The average market capitalization across the group is 9.68M. The market cap for tickers in the group ranges from 8.02M to 11.35M. SNSE holds the highest valuation in this group at 11.35M. The lowest valued company is INAB at 8.02M.

High and low price notable news

The average weekly price growth across all stocks in the group was -10%. For the same group, the average monthly price growth was -1%, and the average quarterly price growth was 13%. INAB experienced the highest price growth at -5%, while SNSE experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the group was -53%. For the same stocks of the group, the average monthly volume growth was 23% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 9
P/E Growth Rating: 100
Price Growth Rating: 61
SMR Rating: 98
Profit Risk Rating: 100
Seasonality Score: (-100 ... +100)
VS
INAB vs. SNSE commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INAB is a Hold and SNSE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 14, 2025
Stock price -- (INAB: $1.73 vs. SNSE: $9.00)
Brand notoriety: INAB and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INAB: 51% vs. SNSE: 47%
Market capitalization -- INAB: $7.79M vs. SNSE: $10.78M
INAB [@Biotechnology] is valued at $7.79M. SNSE’s [@Biotechnology] market capitalization is $10.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INAB’s FA Score shows that 1 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • INAB’s FA Score: 1 green, 4 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, both INAB and SNSE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INAB’s TA Score shows that 4 TA indicator(s) are bullish while SNSE’s TA Score has 4 bullish TA indicator(s).

  • INAB’s TA Score: 4 bullish, 5 bearish.
  • SNSE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SNSE is a better buy in the short-term than INAB.

Price Growth

INAB (@Biotechnology) experienced а -4.95% price change this week, while SNSE (@Biotechnology) price change was -14.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNSE($10.8M) has a higher market cap than INAB($7.79M). SNSE YTD gains are higher at: -8.182 vs. INAB (-77.579). INAB has higher annual earnings (EBITDA): -18.37M vs. SNSE (-23.66M). SNSE has more cash in the bank: 25M vs. INAB (10.7M). SNSE has less debt than INAB: SNSE (2.02M) vs INAB (2.96M). INAB (0) and SNSE (0) have equivalent revenues.
INABSNSEINAB / SNSE
Capitalization7.79M10.8M72%
EBITDA-18.37M-23.66M78%
Gain YTD-77.579-8.182948%
P/E RatioN/AN/A-
Revenue00-
Total Cash10.7M25M43%
Total Debt2.96M2.02M146%
TECHNICAL ANALYSIS
Technical Analysis
INABSNSE
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
68%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INAB
Daily Signal:
Gain/Loss:
SNSE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSM9.780.24
+2.52%
Fortuna Mining Corp
CHD83.570.26
+0.31%
Church & Dwight Co
KRNT14.26-0.10
-0.70%
Kornit Digital Ltd
TORO5.17-0.09
-1.71%
Toro Corp
EEIQ0.32-0.01
-1.79%
EpicQuest Education Group International Limited

INAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INAB has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INAB jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INAB
1D Price
Change %
INAB100%
-2.26%
IDYA - INAB
47%
Loosely correlated
-0.24%
GRI - INAB
41%
Loosely correlated
-56.45%
SNSE - INAB
37%
Loosely correlated
+5.02%
ZNTL - INAB
35%
Loosely correlated
+2.11%
HOWL - INAB
34%
Loosely correlated
+1.87%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+5.02%
VSTM - SNSE
47%
Loosely correlated
-5.79%
ALZN - SNSE
40%
Loosely correlated
+0.93%
MOLN - SNSE
39%
Loosely correlated
+4.67%
INAB - SNSE
37%
Loosely correlated
-2.26%
FATE - SNSE
36%
Loosely correlated
+1.83%
More